Triantafyllos Stylianopoulos

Molecular Biology · 2007–2014

A researcher in the Science corpus: 8 papers; trusts 10 researchers and is trusted by 6 researchers here, as inferred from the citation graph.

Subfields

Whom Triantafyllos Stylianopoulos trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Rakesh K. Jain
  2. Peter Carmeliet
  3. Ricky T. Tong
  4. Y. Boucher
  5. Vikash P Chauhan
  6. B. Diop-Frimpong
  7. M. Egeblad
  8. Paolo P. Provenzano

Who trusts Triantafyllos Stylianopoulos overall

  1. Rakesh K. Jain
  2. You Han Bae
  3. Vikash P Chauhan
  4. Jun Wu
  5. N. Bertrand
  6. Alexandre Albanese
  7. John D. Martin
  8. U. Prabhakar
  9. T. Lammers
  10. Kinam Park

Papers from Triantafyllos Stylianopoulos's perspective

Ordered by how strongly the researchers Triantafyllos Stylianopoulos trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Pathology: Cancer cells compress intratumour vessels (Nature)
  2. Normalizing tumor vasculature with anti-angiogenic therapy: A new paradigm for combination therapy (Nature Medicine)
  3. Role of extracellular matrix assembly in interstitial transport in solid tumors. (Cancer Research)
  4. Tensional homeostasis and the malignant phenotype. (Cancer Cell)
  5. Angiogenesis in life, disease and medicine (Nature)
  6. Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice. (Cancer Cell)
  7. Role of tumor–host interactions in interstitial diffusion of macromolecules: Cranial vs. subcutaneous tumors (Proceedings of the National Academy of Sciences of the United States of America)
  8. Vascular Normalization by Vascular Endothelial Growth Factor Receptor 2 Blockade Induces a Pressure Gradient Across the Vasculature and Improves Drug Penetration in Tumors (Cancer Research)
  9. Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin signaling (Cell)
  10. Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma (Cancer Cell)

Their papers